España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Natera
NTRA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$176.27
8.05
4.79%
At close: -
$176.27
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Natera (NTRA) Forecast
News
Earnings
Natera (NTRA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Natera (NASDAQ:NTRA) Stock
Natera Stock (NASDAQ: NTRA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, January 28, 2025
Goldman Sachs Maintains Buy on Natera, Raises...
Benzinga Newsdesk
Monday, January 27, 2025
Reported Saturday, Natera Reports Results Fro...
Benzinga Newsdesk
Thursday, January 23, 2025
Barclays Initiates Coverage On Natera with Ov...
Benzinga Newsdesk
Wednesday, January 22, 2025
Natera shares are trading higher after the co...
Benzinga Newsdesk
Reported Earlier, Natera To Reveal New Insigh...
Benzinga Newsdesk
Monday, January 20, 2025
Looking Into Natera's Recent Short Interest
Benzinga Insights
Sunday, January 19, 2025
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Lekha Gupta
Friday, January 17, 2025
The End Of The 60/40 Portfolio
David Pinsen
Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
Guggenheim Maintains Buy on Natera, Raises Pr...
Benzinga Newsdesk
Wednesday, January 15, 2025
Natera To Provide Roadmap And Outlook At J.P...
Benzinga Newsdesk
Monday, January 13, 2025
Natera shares are trading higher after the co...
Benzinga Newsdesk
Natera Reports Preliminary 2024 Results: $1.7...
Benzinga Newsdesk
Friday, January 10, 2025
The Analyst Verdict: Natera In The Eyes Of 14 Experts
Benzinga Insights
Bernstein Maintains Outperform on Natera, Rai...
Benzinga Newsdesk
Friday, January 03, 2025
Natera shares are trading higher after Canacc...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Natera, Ra...
Benzinga Newsdesk
Tuesday, December 24, 2024
Stanley Druckenmiller Dumps Street's Hottest AI Stocks — Here's What The Billionaire Investor Is Betting On Next
Rounak Jain
Friday, December 20, 2024
Stanley Druckenmiller's Top Holding Has Outperformed Its Sector By 252%
Hayden Buckfire
Friday, December 13, 2024
Market Whales and Their Recent Bets on NTRA Options
Benzinga Insights
JP Morgan Maintains Overweight on Natera, Rai...
Benzinga Newsdesk
Natera shares are trading higher. The stock m...
Benzinga Newsdesk
Thursday, December 12, 2024
Natera Announces Enrollment Of First Patients...
Benzinga Newsdesk
Monday, December 09, 2024
Natera Announces Launch Of iPRS For Breast Ca...
Benzinga Newsdesk
Monday, December 02, 2024
Looking Into Natera's Recent Short Interest
Benzinga Insights
Natera Announces That Obstetrics & Gynecology...
Benzinga Newsdesk
Wednesday, November 27, 2024
Natera Announces Its Prospera Lung Test Has M...
Benzinga Newsdesk
Tuesday, November 26, 2024
Reported Earlier, Natera To Present Latest Da...
Benzinga Newsdesk
Monday, November 25, 2024
Guardant Health Says Jury Unanimously Rejecte...
Benzinga Newsdesk
Natera Issues Statement On Guardant Health Li...
Benzinga Newsdesk
Monday, November 18, 2024
Analyst Expectations For Natera's Future
Benzinga Insights
Piper Sandler Maintains Overweight on Natera,...
Benzinga Newsdesk
Thursday, November 14, 2024
Morgan Stanley Maintains Overweight on Natera...
Benzinga Newsdesk
Wednesday, November 13, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Natera Analysts Increase Their Forecasts Following Upbeat Results
Avi Kapoor
TD Cowen Maintains Buy on Natera, Raises Pric...
Benzinga Newsdesk
Stocks Edge Higher, Dollar Hits 1-Year Peak, Bitcoin Soars To $93,000: What's Driving Markets Wednesday?
Piero Cingari
Craig-Hallum Maintains Buy on Natera, Raises ...
Benzinga Newsdesk
Paymentus Posts Better-Than-Expected Earnings, Joins Dave, Honest Company, Natera, CAVA Group And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
JP Morgan Maintains Overweight on Natera, Rai...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Natera, Ra...
Benzinga Newsdesk
Starbucks To $77? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
Market-Moving News for November 13th
Benzinga Newsdesk
Baird Maintains Outperform on Natera, Raises ...
Benzinga Newsdesk
Natera shares are trading higher after the co...
Benzinga Newsdesk
Tuesday, November 12, 2024
Natera shares are trading higher after the co...
Benzinga Newsdesk
Natera Sees FY24 SG&A $775M-$825M; R&D $375M-...
Benzinga Newsdesk
Natera Sees FY24 Revenue $1.61B-$1.64B Vs $1....
Benzinga Newsdesk
Natera Q3 2024 GAAP EPS $(0.26) Beats $(0.58)...
Benzinga Newsdesk
Stocks Fall On Tariffs Fears, Dollar Hits 6-Month Peak, Yen Tumbles: What's Driving Markets Tuesday?
Piero Cingari
Show More